SCHEMBL30018331

SCHEMBL30018331

COc1cc2cc3ccoc3c(-c3cnc(N4CCCC(C)C4)nc3)c2cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.43
TP53 P04637 2/20 0.40
POLB P06746 1/20 0.40
ADRA1D P25100 4/20 0.37
ADRA1B P35368 4/20 0.37
ADRA1A P35348 3/20 0.37
MTOR P42345 1/20 0.37
KMT5A Q9NQR1 1/20 0.35
LRRK2 Q5S007 4/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GALR3 O60755 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PDE3A Q14432 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30018774 0.89 ADRB2 (0.42) ADRB2TP53POLBADRA1AKDM4E
SCHEMBL30019066 0.89 GAK (0.39) TP53POLBADRA1BADRA1AMAPT
SCHEMBL30018376 0.82 IL2 (0.45) ADRA1BADRA1AMAPTSUV39H2
SCHEMBL30018477 0.82 PDE10A (0.45) MTORMAPTKDM4EALDH1A1HPGD
SCHEMBL30018731 0.82 CCR4 (0.43) ADRA1BADRA1ASUV39H2
SCHEMBL30018471 0.82 GAK (0.38) ADRA1BADRA1A
SCHEMBL30019339 0.79 PDE10A (0.44) TP53POLBMAPT
SCHEMBL30018686 0.79 PDE10A (0.46) LMNATSHRPDE3A
SCHEMBL31216840 0.78 PDE1A (0.53) ADRB2TP53POLBADRA1DADRA1B
SCHEMBL30019303 0.75 PDE10A (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022208382-A1 NOVEL DIALKOXYNAPHTHO[2,3-C]FURAN-1(3H)-ONE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASE OR SARS-COV-2 INFECTION DISEASE, COMPRISING SAME 동화약품주식회사 2022-10-06 WO disclosed